PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective
Current cancer therapies are based mainly on the use of compounds that cause DNA damage. Unfortunately, even the combination therapies do not give rewarding effects, due to the high efficiency of DNA damage repair mechanisms in tumor cells. Therefore, the present studies should be focused on protein...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2016-04-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://phmd.pl/gicid/01.3001.0009.6809 |